My brother, Alvin Prasad, was diagnosed with Myxoid Liposarcoma 10 years ago. On February 7, 2026, Alvin lost his long and courageous battle with cancer.

Throughout his journey, Alvin faced his diagnosis with incredible strength, resilience, and unwavering positivity. He endured intense treatments, including 120 hours of continuous chemotherapy, while exploring every possible option in his fight against this disease.

No matter the challenge, Alvin remained the most positive person throughout his battle. He accepted the cards he was dealt and faced every obstacle with determination and courage.

“I don’t want any pity from anyone — I got this. Every obstacle that comes my way, I remind myself it’s going to be OK. Just do it.”

— Alvin Prasad

Thanks to Race to Cure Sarcoma events, the Sarcoma Foundation of America has invested more than $20 million in sarcoma research. This funding has supported over 200 research grants across 12 countries and contributed to nearly 200 scientific publications. These efforts have also helped generate more than $26 million in additional funding, supported over 10 clinical trials with more pending, and led to two patents.

Your support of Race to Cure Sarcoma is more than participation in an event — it is an investment in research, hope, and saving lives.